Back | Next |
home / stock / enta / enta message board
Subject | By | Source | When |
---|---|---|---|
Thank you. ; ) | willyw | investorshub | 04/25/2023 3:12:09 PM |
Snagged 1,000 shares. Too cheap to pass | rwwine | investorshub | 04/25/2023 3:05:39 PM |
Running out of $. Need to keep that | Jake2234 | investorshub | 04/25/2023 1:04:26 PM |
$ENTAs partial monetization of the Mavyret royalty stream | DewDiligence | investorshub | 04/25/2023 1:02:41 PM |
Enanta Pharmaceuticals Announces Sale of a Portion of | rwwine | investorshub | 04/25/2023 12:35:00 PM |
Price now last up | willyw | investorshub | 04/24/2023 9:50:06 AM |
Vin, sorry, I was addressing the guy who | vinmantoo | investorshub | 04/22/2023 1:03:04 AM |
So if you look at the details of | Jake2234 | investorshub | 04/21/2023 10:17:34 PM |
Vin, sorry, I was addressing the guy who | Fred Kadiddlehopper | investorshub | 04/21/2023 9:53:54 PM |
Please explain your thinking. | vinmantoo | investorshub | 04/21/2023 9:18:00 PM |
Sure. 400K net shares have not been purchased | Jake2234 | investorshub | 04/21/2023 8:14:02 PM |
Please explain your thinking. | Fred Kadiddlehopper | investorshub | 04/21/2023 7:19:41 PM |
Your analysis, vinman, is misleading. | Jake2234 | investorshub | 04/21/2023 7:01:32 PM |
$ENTAs GC exercised and held $250K of stock | vinmantoo | investorshub | 04/21/2023 4:20:41 PM |
Roy, could you also put this purchase in | Jake2234 | investorshub | 04/21/2023 10:53:19 AM |
All told, the transaction should be construed as | vinmantoo | investorshub | 04/20/2023 9:00:56 PM |
Thanks. So he probably saw the low share | Jake2234 | investorshub | 04/20/2023 8:40:08 PM |
The overall cash outlay was roughly $220K: $200K | DewDiligence | investorshub | 04/20/2023 8:25:38 PM |
Agreed. But specifically, how much cash did he | Jake2234 | investorshub | 04/20/2023 6:59:24 PM |
Exercising the options starts the one-year clock for | DewDiligence | investorshub | 04/20/2023 5:53:26 PM |
News, Short Squeeze, Breakout and More Instantly...
Enanta Pharmaceuticals Inc. Company Name:
ENTA Stock Symbol:
NASDAQ Market:
Enanta Pharmaceuticals Inc. Website:
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for virology and immunology indications, today announced that Jay R. Luly, Ph.D., President and Chief Executive Officer, and Tara L. Kieffer, Ph.D., Chief Product Strate...
2024-05-10 16:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
A look at the top 10 most actives in the United States Nuwellis Inc. (NUWE) rose 60.3% to $0.2741 on volume of 66,284,094 shares Faraday Future Intelligent Electric Inc. (FFIE) rose 21.1% to $0.05 on volume of 64,247,106 shares Clearmind Medicine Inc. (CMND) rose 37.6% to $1.61 on volume ...